Citius (CTXR) CEO Myron Holubiak Live on TV, 1:20 Today, June 30th.
VIDEO: Citius CEO Myron Holubiak to Appear on TD Ameritrade Network's The Watch List with Nicole Petallides
LIVE CHART
- Live on-air interview to feature Citius...
Citius Pharma (CTXR) On The Move.
One Of Our Top 5 Biotech Picks For 2020 Up 23% Yesterday, Indicating Up Another 24% This Morning. Inquiring Minds Want To Know!
Citius (a...
Meet The Billion-Dollar Family Company That Makes Purell (Forbes).
Jerry and Goldie Lippman cofounded Gojo in Akron, Ohio, in 1946.
Forbes 3/20/2020
Panic buying is one of the most visible symptoms of coronavirus hysteria, with crazed shoppers emptying grocery store...
Corona Craziness Continues. Immuron (IMRN) Gains 10-Fold or 1000%, in 3 Months!
Too bad we don’t trade for a living! We don’t even use real-time quotes, LOL. $2.57 to $27.13, from March 3rd – what...
11:00 AM Webinar Today, Checkpoint Therapeutics (CKPT) CEO James Olivero.
Virtually meet the CEO of Checkpoint, James Oliviero, on May 28th at 11 am for an update on their two most advanced programs.
Checkpoint is evaluating...
Immunomedics (IMMU) $33 | Raising Price Potential to $60. American BriVision (ABVC) $3.00 |...
We Are Raising the Price Potential of Immunomedics (IMMU) to $60, Highest on the Street, and Initiating Coverage on Another $3.00 Medical Start-Up American...
Corona Craziness Continues. Organicell (BPSR) Gains 10-fold or 1000%, in Six Weeks.
Too bad we don't trade for a living! We don't even use real-time quotes, LOL. $0.02 to $0.27, from Easter - what HOOT-N-HOLLER.
LIVE CHART
RELATED:...
Organicell (BPSR) a Triple Since Easter.
Slowly she turns, step-by-step. $20 million gain in market value. Spurred by FDA Emergency IND's.
RELATED: Adding Organicell (BPSR) $0.02 to the Watch List.
FDA Approves...
After FDA authorizes at-home saliva test for Covid-19, startups begin selling test kits.
MedCityNews
The FDA gave an emergency use authorization for the first saliva-based Covid-19 test developed by RUCDR Infinite Biologics. Now, startups are once again trying...
Biotech Stock Review Adds One Medical (ONEM) $28.50 to Watchlist.
It Ain't Cheap at $3.5 Billion.It's Near Doubled Since March 20th.But Look at the Growth.Look at the Cash.Don't Look at the Bottom Line.And it's...















